Xontogeny is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients with serious diseases. The Company partners with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.

Xontogeny is assembling a senior team of life science professionals with deep experience in drug development to advance a select portfolio of product candidates and technologies in ventures that are focused across a number of serious disease areas from preclinical through clinical proof-of-concept studies.

Type
Private
HQ
Boston, US
Founded
2016
Size (employees)
3 (est)
Xontogeny was founded in 2016 and is headquartered in Boston, US
Report incorrect company information

Xontogeny Office Locations

Xontogeny has an office in Boston
Boston, US (HQ)
500
Show all (1)
Report incorrect company information

Xontogeny Financials and Metrics

Summary Metrics

Founding Date

2016

Total Funding

$15 m

Latest funding size

$15 m

Time since last funding

9 months ago

Investors

Xontogeny's latest funding round in May 2017 was reported to be $15 m. In total, Xontogeny has raised $15 m
Report incorrect company information